The P.L.A.Y. Project Awarded $1.85 Million SBIR to Study Autism Therapy; Receives Help from Biotechnology Business Consultants

The P.L.A.Y.® Project (P.L.A.Y. and Language for Autistic Youngsters) was recently awarded a $1.85 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health. The P.L.A.Y. Project worked with Biotechnology Business Consultants (BBC) to secure the award that will fund a two-year effectiveness study. Read more...

Alluvium Awarded $323,000 Phase I SBIR; Receives Michigan-funded Help from Biotechnology Business Consultants

Alluvium Biosciences, a spin out company from the University of Michigan, was recently awarded a $323,000 Phase I Small Business Technology Transfer (STTR) grant. Alluvium worked with Biotechnology Business Consultants (BBC) to secure the funding award that will support the company’s work to produce a library of natural product analogs and to screen for anti-cancer properties. Read more...

BBC Helps Piezo Resonance Innovations, Inc.
Win 2 SBIR Phase I Awards

Founded in 2006, Piezo Resonance Innovations, Inc. (PRII) is a Pennsylvania-based company that develops innovative medical devices through the integration of smart actuation. PRII uses federal grants, commercial partnerships and economic development growth opportunities and incentives to fund the development of its medical devices. Read more...

BBC Helps JADI Secure Pre-Seed Funding

JADI, Inc.’s expertise is the exploration, research and development of diverse technologies associated with unmanned robotic systems. The company builds strategic relationships with commercial companies, universities and government agencies that will enhance the commercialization of its patented technologies. Read more...

Biotechnology Business Consultants Helps
NanoVir Secure Two NIH Grants

Co-founded by Chris Fisher, PhD, and Jim Bashkin, D.Phil., in 2003, NanoVir, LLC is a Kalamazoo pharmaceutical discovery and development company focused on antiviral treatments for human papillomavirus, or HPV. HPV is the cause of cervical cancer and abnormal Pap smears. NanoVir’s discoveries are aimed at the millions of people who are not candidates for vaccination due to age or current HPV infection. Read more...

BBC Helps Compendia Bioscience with SBIR Proposal,
Resulting in $2.4 M in Funding

For Compendia Bioscience, CEO John Freshley knew SBIR grant funding was an option to support the company’s growth. Unfortunately, Freshley, a seasoned and experienced entrepreneur who had successfully launched several companies, did not have expertise in grant funding. Freshley’s experience did teach him to rely on experts to supplement the talent of his own team, so he reached out to Biotechnology Business Consultants (BBC) to help Compendia navigate the grant process. Read more...

The PLAY Project Obtains SBIR Grant from NIH, Expanding its Reach to Children with Autism and Their Parents

The PLAY Project (Play and Language for Autistic Youngsters), based in Ann Arbor, Mich., trains parents to play with their child with autism. The specific form of play developed by the Project’s founder, Richard Solomon, MD, in 2004, treats the core deficits of autism and helps bring the child out of their social isolation and learn the foundations for communication. Read more...

BBC Helps Touchstone Innovations Obtain STTR Funding, Business Acceleration

Touchstone Innovations, formerly known as Hamztec, LLC, is a medical device development organization specializing in awareness and monitoring equipment. Focused on mental health sciences, the company is a fledgling start-up with aggressive plans to ramp up operations and growth. Read more...

BBC and iBIO Institute Help Midwest Companies Secure Funding

The iBIO Institute serves the business and academic communities in Illinois and the Midwest region. Established to provide educational, training and research opportunities, the iBIO Institute is a resource that supports healthcare, agriculture, industrial and environmental breakthroughs. Read more...

BBC Helps Cohera: SBIR Funding Supports Development
of Commercially Viable Product

Cohera Medical, Inc., a University of Pittsburg spin-out, is working to fulfill the market demand for a strong, safe tissue adhesive to improve the wound closure process after plastic surgery procedures. Its flagship adhesive product, TissuGlu™, positions tissues for optimal healing while minimizing the fluid accumulation in the wound that can sometimes lead to post-surgical complications. Read more...